Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Leirisalo-Repo

Showing results (101-110 of 251) with videos related to

Pageof 26
Sort By:
Annals of the Rheumatic Diseases|May 14, 2004
Cytokine and chemokine receptor profile of peripheral blood mononuclear cells during treatment with infliximab in patients with active rheumatoid arthritisR Nissinen, M Leirisalo-Repo, R Peltomaa, et al.
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1994
[Relationship between intestinal inflammation and arthritis]P Helenius, U Turunen, S Stenman, et al.
Clinical and Experimental Rheumatology|May 29, 2009
Early improvement of health-related quality of life during treatment with etanercept and adalimumab in patients with rheumatoid arthritis in routine practiceK Laas, R Peltomaa, K Puolakka, et al.
Scandinavian Journal of Rheumatology|August 3, 2006
Infectious causes of death in patients with rheumatoid arthritis: an autopsy studyR Koivuniemi, M Leirisalo-Repo, R Suomalainen, et al.
Annals of the Rheumatic Diseases|June 9, 2005
Low circulating soluble interleukin 2 receptor level predicts rapid response in patients with refractory rheumatoid arthritis treated with infliximabA Kuuliala, R Nissinen, H Kautiainen, et al.
Arthritis and Rheumatism|June 17, 2000
Antineutrophil cytoplasmic antibodies in patients with early rheumatoid arthritis: an early marker of progressive erosive diseaseA Mustila, L Paimela, M Leirisalo-Repo, et al.
British Journal of Rheumatology|December 1, 1995
Prognostic value of quantitative measurement of rheumatoid factor in early rheumatoid arthritisL Paimela, T Palosuo, M Leirisalo-Repo, et al.
Arthritis and Rheumatism|January 1, 1994
High frequency of silent inflammatory bowel disease in spondylarthropathyM Leirisalo-Repo, U Turunen, S Stenman, et al.
Arthritis and Rheumatism|July 1, 1991
Serum hyaluronate level as a predictor of radiologic progression in early rheumatoid arthritisL Paimela, A Heiskanen, P Kurki, et al.
Rheumatology International|August 24, 2001
Increased level of YKL-40 in sera from patients with early rheumatoid arthritis: a new marker for disease activityR Peltomaa, L Paimela, S Harvey, et al.
Pageof 26

Showing results (101-110 of 251) with videos related to

Sort By:
Pageof 26
Annals of the Rheumatic Diseases|May 14, 2004
Cytokine and chemokine receptor profile of peripheral blood mononuclear cells during treatment with infliximab in patients with active rheumatoid arthritisR Nissinen, M Leirisalo-Repo, R Peltomaa, et al.
Duodecim; Laaketieteellinen Aikakauskirja|January 1, 1994
[Relationship between intestinal inflammation and arthritis]P Helenius, U Turunen, S Stenman, et al.
Clinical and Experimental Rheumatology|May 29, 2009
Early improvement of health-related quality of life during treatment with etanercept and adalimumab in patients with rheumatoid arthritis in routine practiceK Laas, R Peltomaa, K Puolakka, et al.
Scandinavian Journal of Rheumatology|August 3, 2006
Infectious causes of death in patients with rheumatoid arthritis: an autopsy studyR Koivuniemi, M Leirisalo-Repo, R Suomalainen, et al.
Annals of the Rheumatic Diseases|June 9, 2005
Low circulating soluble interleukin 2 receptor level predicts rapid response in patients with refractory rheumatoid arthritis treated with infliximabA Kuuliala, R Nissinen, H Kautiainen, et al.
Arthritis and Rheumatism|June 17, 2000
Antineutrophil cytoplasmic antibodies in patients with early rheumatoid arthritis: an early marker of progressive erosive diseaseA Mustila, L Paimela, M Leirisalo-Repo, et al.
British Journal of Rheumatology|December 1, 1995
Prognostic value of quantitative measurement of rheumatoid factor in early rheumatoid arthritisL Paimela, T Palosuo, M Leirisalo-Repo, et al.
Arthritis and Rheumatism|January 1, 1994
High frequency of silent inflammatory bowel disease in spondylarthropathyM Leirisalo-Repo, U Turunen, S Stenman, et al.
Arthritis and Rheumatism|July 1, 1991
Serum hyaluronate level as a predictor of radiologic progression in early rheumatoid arthritisL Paimela, A Heiskanen, P Kurki, et al.
Rheumatology International|August 24, 2001
Increased level of YKL-40 in sera from patients with early rheumatoid arthritis: a new marker for disease activityR Peltomaa, L Paimela, S Harvey, et al.
Pageof 26